Vicapsys Life Sciences, Inc.
VICP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $63 | $57 | $60 | $60 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $63 | $57 | $61 | $60 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.005 | -0.007 | -0.007 | -0.006 |
| % Growth | 30.1% | -5.8% | -23.2% | – |
| Operating Cash Flow | – | – | $0 | $0 |
| Capital Expenditures | – | – | -$0 | $0 |
| Free Cash Flow | – | – | $0 | $0 |